Yescarta IV injection contains Axicabtagene Silorucel (YJ code: 4900405X1024, per patient) and is manufactured by Gilead Science. It is a CD19-directed chimeric antigen receptor T cell (CAR T) therapy approved for adults with certain forms of large B-cell lymphoma and follicular lymphoma that are relapsed or refractory.
Yescarta IV injection
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →